Leukocyte cell-derived chemotaxin 2 antagonizes MET receptor activation to suppress hepatocellular carcinoma vascular invasion by protein tyrosine phosphatase 1B recruitment

Chi Kuan Chen, Ching Yao Yang, Kuo Tai Hua, Ming Chih Ho, Gunnar Johansson, Yung Ming Jeng, Chiung Nien Chen, Min Wei Chen, Wei Jiunn Lee, Jen Liang Su, Tsung Ching Lai, Chi Chi Chou, Bing Ching Ho, Chuan Fa Chang, Po Huang Lee, King Jen Chang, Michael Hsiao, Ming Tsan Lin, Min Liang Kuo

研究成果: 雜誌貢獻文章

28 引文 斯高帕斯(Scopus)

摘要

Leukocyte cell-derived chemotoxin 2 (LECT2) has been shown to act as a tumor suppressor in hepatocellular carcinoma (HCC). However, the underlying mechanism has not yet been completely defined. Here, we employ a LECT2-affinity column plus liquid chromatography coupled with tandem mass spectrometry to identify LECT2-binding proteins and found that MET receptor strongly interacted with LECT2 protein. Despite the presence of hepatocyte growth factor, the LECT2 binding causes an antagonistic effect to MET receptor activation through recruitment of protein tyrosine phosphatase 1B. The antagonistic effect of LECT2 on MET activation also mainly contributes to the blockage of vascular invasion and metastasis of HCC. Furthermore, serial deletions and mutations of LECT2 showed that the HxGxD motif is primarily responsible for MET receptor binding and its antagonistic effects. Conclusion: These findings reveal a novel, specific inhibitory function of LECT2 in HCC by the direct binding and inactivation of MET, opening a potential avenue for treating MET-related liver cancer. (Hepatology 2014;59:974-985).
原文英語
頁(從 - 到)974-985
頁數12
期刊Hepatology
59
發行號3
DOIs
出版狀態已發佈 - 三月 2014

ASJC Scopus subject areas

  • Hepatology

指紋 深入研究「Leukocyte cell-derived chemotaxin 2 antagonizes MET receptor activation to suppress hepatocellular carcinoma vascular invasion by protein tyrosine phosphatase 1B recruitment」主題。共同形成了獨特的指紋。

  • 引用此

    Chen, C. K., Yang, C. Y., Hua, K. T., Ho, M. C., Johansson, G., Jeng, Y. M., Chen, C. N., Chen, M. W., Lee, W. J., Su, J. L., Lai, T. C., Chou, C. C., Ho, B. C., Chang, C. F., Lee, P. H., Chang, K. J., Hsiao, M., Lin, M. T., & Kuo, M. L. (2014). Leukocyte cell-derived chemotaxin 2 antagonizes MET receptor activation to suppress hepatocellular carcinoma vascular invasion by protein tyrosine phosphatase 1B recruitment. Hepatology, 59(3), 974-985. https://doi.org/10.1002/hep.26738